Back to medications
Medication monograph
pazopanib
Tyrosine Kinase InhibitorsVEGF InhibitorsAntineoplasticsKinase Inhibitor
Clinical reference
Product monograph
VOTRIENT- pazopanib hydrochloride tablet, film coated
Brands & formulations
Family members
Pricing
Price information
Votrient Tablet (Limited Stock)
Novartis · 200 mg
120: $7857.13
Pazopanib Tablet
Generic · 200 mg
120: $6428.56
Classification
- Chemical class
- Tyrosine Kinase Inhibitors, VEGF Inhibitors
- Clinical class
- Antineoplastics
- Banks class
- Kinase Inhibitor